13.03
[1]. Olszewski RT, et al. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR. J Neurochem. 200 May;8():876-8.
[2]. Yamamoto T, et al. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-3 in the rat formalin test and in the rat neuropathic pain model. Eur J Neurosci. 200 Jul;20(2):83-.
![]()
![]()